Program Anniversary Celebration

From Basic Research to Pharmaceutical Breakthrough

March 16, 2010

Gehry Building Novartis, Basel

13.00 Welcome
Prof. Paul Herrling, Head of Corporate Research, Novartis
Opening words
Dr. Christoph Eymann, Regierungsrat Basel-Stadt

13.15 Shaping the future: The FMI in 2010
Prof. Susan M. Gasser, Director, Friedrich Miescher Institute for Biomedical Research

13.20 A new academia-industry partnership for the info-nano-bio convergence?
Prof. Patrick Aebischer, President, EPFL

14.00 Restoring vision: From mice to men
Dr. Botond Roska, Junior Group Leader, FMI

14.20 mTOR : A validated target for the treatment of human cancer
Dr. Heidi Lane, Head of Cancer Biology, Basilea

14.40 Clinical development of everolimus in oncology: Afinitor is born
Dr. Michel Maira, Senior Research Investigator I, NIBR

15.00 Changing the grammar of drug discovery
Prof. Mark C. Fishman, President, Novartis Institutes for BioMedical Research (NIBR)

Coffee break

16.20 Regulation of genes by epigenetic repression
Dr. Dirk Schübeler, Senior Group Leader, FMI

16.40 Understanding complexes that safeguard the genome
Dr. Nicolas Thomä, Junior Group Leader, FMI

17.00 How discovery research works and why it matters
Sir Paul M. Nurse, President, Rockefeller University



» Invitation


For more information please contact the Organizing Committee.
About this site2018 © FMI Basel Switzerland